314 related articles for article (PubMed ID: 18567600)
1. Insulin-like growth factor-I analogue protects muscles of dystrophic mdx mice from contraction-mediated damage.
Gehrig SM; Ryall JG; Schertzer JD; Lynch GS
Exp Physiol; 2008 Nov; 93(11):1190-8. PubMed ID: 18567600
[TBL] [Abstract][Full Text] [Related]
2. Systemic administration of IGF-I enhances oxidative status and reduces contraction-induced injury in skeletal muscles of mdx dystrophic mice.
Schertzer JD; Ryall JG; Lynch GS
Am J Physiol Endocrinol Metab; 2006 Sep; 291(3):E499-505. PubMed ID: 16621899
[TBL] [Abstract][Full Text] [Related]
3. Modulation of insulin-like growth factor (IGF)-I and IGF-binding protein interactions enhances skeletal muscle regeneration and ameliorates the dystrophic pathology in mdx mice.
Schertzer JD; Gehrig SM; Ryall JG; Lynch GS
Am J Pathol; 2007 Oct; 171(4):1180-8. PubMed ID: 17823291
[TBL] [Abstract][Full Text] [Related]
4. Administration of insulin-like growth factor-I improves fatigue resistance of skeletal muscles from dystrophic mdx mice.
Gregorevic P; Plant DR; Lynch GS
Muscle Nerve; 2004 Sep; 30(3):295-304. PubMed ID: 15318340
[TBL] [Abstract][Full Text] [Related]
5. Enhanced dystrophic progression in mdx mice by exercise and beneficial effects of taurine and insulin-like growth factor-1.
De Luca A; Pierno S; Liantonio A; Cetrone M; Camerino C; Fraysse B; Mirabella M; Servidei S; Rüegg UT; Conte Camerino D
J Pharmacol Exp Ther; 2003 Jan; 304(1):453-63. PubMed ID: 12490622
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic potential of PEGylated insulin-like growth factor I for skeletal muscle disease evaluated in two murine models of muscular dystrophy.
Gehrig SM; van der Poel C; Hoeflich A; Naim T; Lynch GS; Metzger F
Growth Horm IGF Res; 2012 Apr; 22(2):69-75. PubMed ID: 22424862
[TBL] [Abstract][Full Text] [Related]
7. An octaguanidine-morpholino oligo conjugate improves muscle function of mdx mice.
Widrick JJ; Jiang S; Choi SJ; Knuth ST; Morcos PA
Muscle Nerve; 2011 Oct; 44(4):563-70. PubMed ID: 21922468
[TBL] [Abstract][Full Text] [Related]
8. Phenotypic improvement of dystrophic muscles by rAAV/microdystrophin vectors is augmented by Igf1 codelivery.
Abmayr S; Gregorevic P; Allen JM; Chamberlain JS
Mol Ther; 2005 Sep; 12(3):441-50. PubMed ID: 16099410
[TBL] [Abstract][Full Text] [Related]
9. Improved contractile function of the mdx dystrophic mouse diaphragm muscle after insulin-like growth factor-I administration.
Gregorevic P; Plant DR; Leeding KS; Bach LA; Lynch GS
Am J Pathol; 2002 Dec; 161(6):2263-72. PubMed ID: 12466140
[TBL] [Abstract][Full Text] [Related]
10. Chronic exercise accelerates the degeneration-regeneration cycle and downregulates insulin-like growth factor-1 in muscle of mdx mice.
Okano T; Yoshida K; Nakamura A; Sasazawa F; Oide T; Takeda S; Ikeda S
Muscle Nerve; 2005 Aug; 32(2):191-9. PubMed ID: 15937872
[TBL] [Abstract][Full Text] [Related]
11. Comparative evaluation of IGF-I gene transfer and IGF-I protein administration for enhancing skeletal muscle regeneration after injury.
Schertzer JD; Lynch GS
Gene Ther; 2006 Dec; 13(23):1657-64. PubMed ID: 16871234
[TBL] [Abstract][Full Text] [Related]
12. Differential calcineurin signalling activity and regeneration efficacy in diaphragm and limb muscles of dystrophic mdx mice.
Stupka N; Michell BJ; Kemp BE; Lynch GS
Neuromuscul Disord; 2006 May; 16(5):337-46. PubMed ID: 16621557
[TBL] [Abstract][Full Text] [Related]
13. Low dose formoterol administration improves muscle function in dystrophic mdx mice without increasing fatigue.
Harcourt LJ; Schertzer JD; Ryall JG; Lynch GS
Neuromuscul Disord; 2007 Jan; 17(1):47-55. PubMed ID: 17134898
[TBL] [Abstract][Full Text] [Related]
14. Nuclear factor kappa-B blockade reduces skeletal muscle degeneration and enhances muscle function in Mdx mice.
Messina S; Bitto A; Aguennouz M; Minutoli L; Monici MC; Altavilla D; Squadrito F; Vita G
Exp Neurol; 2006 Mar; 198(1):234-41. PubMed ID: 16410003
[TBL] [Abstract][Full Text] [Related]
15. Power output of fast and slow skeletal muscles of mdx (dystrophic) and control mice after clenbuterol treatment.
Lynch GS; Hinkle RT; Faulkner JA
Exp Physiol; 2000 May; 85(3):295-9. PubMed ID: 10825417
[TBL] [Abstract][Full Text] [Related]
16. Targeting the immune system to improve ventilatory function in muscular dystrophy.
Gosselin LE; McCormick KM
Med Sci Sports Exerc; 2004 Jan; 36(1):44-51. PubMed ID: 14707767
[TBL] [Abstract][Full Text] [Related]
17. Targeted expression of insulin-like growth factor-I reduces early myofiber necrosis in dystrophic mdx mice.
Shavlakadze T; White J; Hoh JF; Rosenthal N; Grounds MD
Mol Ther; 2004 Nov; 10(5):829-43. PubMed ID: 15509501
[TBL] [Abstract][Full Text] [Related]
18. Weekly oral prednisolone improves survival and strength in male mdx mice.
Keeling RM; Golumbek PT; Streif EM; Connolly AM
Muscle Nerve; 2007 Jan; 35(1):43-8. PubMed ID: 16969833
[TBL] [Abstract][Full Text] [Related]
19. Effect of creatine supplementation on skeletal muscle of mdx mice.
Louis M; Raymackers JM; Debaix H; Lebacq J; Francaux M
Muscle Nerve; 2004 May; 29(5):687-92. PubMed ID: 15116372
[TBL] [Abstract][Full Text] [Related]
20. The calcineurin signal transduction pathway is essential for successful muscle regeneration in mdx dystrophic mice.
Stupka N; Gregorevic P; Plant DR; Lynch GS
Acta Neuropathol; 2004 Apr; 107(4):299-310. PubMed ID: 14727129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
